(Q48612829)

13 February 2018

title

Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice. (English)

1 reference

13 February 2018

1 reference

1

1 reference

13 February 2018

author name string

Vanessa C Abílio

2

1 reference

13 February 2018

Danila Torres-Leite

3

1 reference

13 February 2018

Marcelo Bergamo

4

1 reference

13 February 2018

Cibele C Chinen

5

1 reference

13 February 2018

Flávia T Claro

6

1 reference

13 February 2018

Rita de Cássia Carvalho

7

1 reference

13 February 2018

Roberto Frussa-Filho

8

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

Behavioural Brain Research

published in

1 reference

13 February 2018

volume

132

1 reference

13 February 2018

issue

2

1 reference

13 February 2018

page(s)

171-177

1 reference

13 February 2018

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Effects of age on a new animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

A Study of Facial Dyskinesia in a Mental Hospital Population

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

1 reference

7 January 2021

Oxygen radicals as key mediators in neurological disease: fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Role of free radicals in aging and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Neuroleptic-induced oral movements in rats: methodological issues.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Oxygen radicals and neuropsychiatric illness. Some speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Tardive dyskinesia on Hungarian psychiatric wards

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Effects of buspirone on an animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Potent Antidopaminergic Activity of Estradiol at the Pituitary Level on Prolactin Release

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

The plus-maze discriminative avoidance task: a new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Spatial learning and memory deficits induced by dopamine administration with decreased glutathione.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Tardive dyskinesia and psychotropic drug history

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

An assessment of tardive dyskinesia in schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Acute reserpine administration elicits long-term spontaneous oral dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Effects of monosialoganglioside on a new model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Estrogens in Tardive Dyskinesia in Male Psychiatric Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

Prevalence of tardive dyskinesia in 3140 French inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900409-0

7 January 2021

10.1016/S0166-4328(01)00409-0

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

11997147

1 reference

13 February 2018